LDLR and pancreatic neoplasm: Some studies have suggested that genetically elevated LDL-cholesterol levels are associated with pancreatic cancer, and inhibiting LDLR in PC cells considerably reduces cholesterol uptake and alters its distribution, leading to decreased cancer cell proliferation (Jung et al., 2021; Yin et al., 2022).